Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
TherapeuticsMD, Inc. (TXMD) had Normalized Income after Taxes of $0.16M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.87M |
|
$0.15M |
|
-- |
|
$0.87M |
|
$1.69M |
|
$-0.82M |
|
$0.98M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.16M |
|
$0.15M |
|
|
Normalized Income after Taxes |
$0.16M |
$-0.82M |
|
$-0.95M |
|
11.57M |
|
11.64M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$16.12M |
|
-- |
|
$21.41M |
|
$37.53M |
|
$5.00M |
|
-- |
|
$5.39M |
|
$10.40M |
|
$27.13M |
|
$23.57M |
|
$27.13M |
|
11.57M |
|
| Cash Flow Statement Financials | |
$1.72M |
|
-- |
|
-- |
|
$7.48M |
|
$9.19M |
|
$1.71M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-93.90% |
|
-93.90% |
|
-- |
|
18.87% |
|
17.84% |
|
$1.72M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.26 |
|
351.51 |
|
0.60% |
|
0.70% |
|
0.44% |
|
0.60% |
|
$2.34 |
|
$0.15 |
|
$0.15 |
|